HAS1 and aberrant novel variants are expressed in PBMCs obtained from most MM and MGUS patients
Sample type . | No. patients . | HAS1Va, % . | HAS1Vb, % . | HAS1Vc, % . | HAS1, % . |
|---|---|---|---|---|---|
| MM PBMCs | 82 | 68 | 46 | 33 | 58 |
| MGUS PBMCs | 58 | 74 | 41 | 9 | 74 |
Sample type . | No. patients . | HAS1Va, % . | HAS1Vb, % . | HAS1Vc, % . | HAS1, % . |
|---|---|---|---|---|---|
| MM PBMCs | 82 | 68 | 46 | 33 | 58 |
| MGUS PBMCs | 58 | 74 | 41 | 9 | 74 |
Numbers indicate percentage of patients whose PBMCs expressed HAS1 and its novel variant. Results were obtained by RT-PCR/DNA fragment analysis, and data analyses were conducted using GeneScan software. HAS1Vc expression is not significantly different between MM and MGUS.